Baldwin Calls For Rejecting Purdue Pharmacy Bankruptcy Plan
Plan shields Sackler family, gives top company executives $5.4 million in bonuses.
Sen. Tammy Baldwin has joined five Senate colleagues in requesting that the United States Bankruptcy Court of the Southern District of New York reject Purdue Pharma’s requests for executive and employee bonuses. Purdue’s requested $34.7 million in employee bonuses, including $5.4 million for its top executives, could amount to more than payouts for victims and families, the senators say.
Baldwin, alongside Sens. Richard Blumenthal (D-Conn.), Joe Manchin (D-W. Va.), Tina Smith (D-Minn.), Maggie Hassan (D-N.H.), and Elizabeth Warren (D-Mass.) wrote a joint letter to Judge Robert Drain requesting that Purdue’s terms be rejected. The senators argued that under Purdue’s plan, about 55 bonus-eligible employees would get up to $67,000. The senators stressed that, “Purdue’s proposed bankruptcy reorganization plan will cap payouts to individual claimants at $48,000, but only in cases where an individual was prescribed OxyContin and died as a direct result. Most victims and their families will receive far less.”
The appearance of fentanyl mixed with drugs like cocaine and methamphetamine is also increasing the death rates from those substances. Drug overdoses accounted for more deaths in America than car crashes, gun violence, and HIV/AIDS combined, Democracy Now reported last week. According to the Centers for Disease Control and Prevention (CDC) there were nearly 500,000 opioid or prescription-involved deaths between 1999 and 2019, with 93,000 in 2020 alone.
Some 15 states recently agreed to abandon their efforts to block Purdue’s bankruptcy plan. In exchange, Purdue will release tens of millions of documents and pay an expected $4.5 billion settlement. The Sackler family, which owns Purdue and reaped more than $12 billion from the company’s profits, will be shielded from being held responsible for the overdose epidemic under the terms of the settlement. In 2007, Purdue plead guilty for criminally misbranding their prescription products.
“It would be contrary to public policy and public health — and a miscarriage of justice — to provide those running an alleged ‘criminal enterprise’ with upwards of $35 million in bonuses, including $5.4 million for top executives,” the senators state in their letter. “As such, we request the funds currently proposed for executive and employee incentive and retention plans instead be made available to victims, their families, and communities.”
Baldwin calls for rejecting Purdue Pharma’s bankruptcy plan was originally published by the Wisconsin Examiner.
More about the Opioid Crisis
- Senator Baldwin Calls on House to Pass Bill that Cracks Down on Fentanyl Traffickers - U.S. Sen. Tammy Baldwin - Feb 15th, 2024
- Attorney General Josh Kaul announces $350 million settlement with marketing firm over its role in opioid epidemic - Wisconsin Department of Justice - Feb 1st, 2024
- Grants Will Fund Recovery Housing For Those Facing Homelessness and Battling Opioids - Margaret Faust - Jan 12th, 2024
- Baldwin Helps Advance Bipartisan Bill to Address Opioid and Fentanyl Crisis - U.S. Sen. Tammy Baldwin - Dec 14th, 2023
- DHS and DOJ Announce Dose of Reality Roundtable Discussions on Wisconsin’s Opioid Epidemic - Wisconsin Department of Health Services - Dec 6th, 2023
- Limited Supply of Narcan Prevents Milwaukee Groups From Saving Lives - Edgar Mendez - Dec 1st, 2023
- MUPD, Wisconsin Voices for Recovery partner to install Nalox-ZONE boxes on Marquette campus - Marquette University - Oct 12th, 2023
- MKE County: Drug Settlements Could Help Expand Opioid Addiction Programs - Graham Kilmer - Sep 21st, 2023
- DHS Awards Funding to Law Enforcement Agencies Working to Address the Opioid Epidemic - Wisconsin Department of Health Services - Sep 21st, 2023
- Milwaukee County Announces Locations of 11 ‘Harm Reduction Vending Machines’ to Combat Death from Overdose - County Executive David Crowley - Aug 8th, 2023
Read more about Opioid Crisis here